The risk of teratogenicity from anti-seizure medicines (ASMs) varies depending on drug type and dosage [1]. Various academic societies have issued warnings about the teratogenicity of ASMs during pregnancy [2,3]. Therefore, the choice of ASM prescribed for pregnant women with epilepsy is important1.
17
ABR
ABR
0